| Ident. | Authors (with country if any) | Title |
|---|
| 000264 (2016) |
Imène Achour [Canada] ; Anne-Marie Arel-Dubeau [Canada] ; Justine Renaud [Canada] ; Manon Legrand [Canada] ; Everaldo Attard [Malte] ; Marc Germain [Canada] ; Maria-Grazia Martinoli [Canada] | Oleuropein Prevents Neuronal Death, Mitigates Mitochondrial Superoxide Production and Modulates Autophagy in a Dopaminergic Cellular Model. |
| 000678 (2015) |
Ross B. Mounsey [Royaume-Uni] ; Sarah Mustafa [Royaume-Uni] ; Lianne Robinson [Royaume-Uni] ; Ruth A. Ross [Canada] ; Gernot Riedel [Royaume-Uni] ; Roger G. Pertwee [Royaume-Uni] ; Peter Teismann [Royaume-Uni] | Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease |
| 000985 (2014) |
Jackalina M. Van Kampen [Canada] ; David B. Baranowski [Canada] ; Christopher A. Shaw [Canada] ; Denis G. Kay | Panax ginseng is neuroprotective in a novel progressive model of Parkinson's disease. |
| 000A35 (2014) |
St Masoud [Canada] ; Lm Vecchio [Canada] ; Y. Bergeron ; Mm Hossain [États-Unis] ; Lt Nguyen [Canada] ; Mk Bermejo [Canada] ; B. Kile [États-Unis] ; Td Sotnikova [Italie, Russie] ; Wb Siesser [États-Unis] ; Rr Gainetdinov [Italie, Russie] ; Rm Wightman [États-Unis] ; Mg Caron [États-Unis] ; Jr Richardson [États-Unis] ; Gw Miller [États-Unis] ; Aj Ramsey [Canada] ; M. Cyr ; A. Salahpour [Canada] | Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and L-DOPA reversible motor deficits |
| 000C97 (2013) |
Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. Park | Perturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)* |
| 001133 (2012) |
Maria Xilouri [Grèce] ; Elli Kyratzi ; Pothitos M. Pitychoutis ; Zoi Papadopoulou-Daifoti ; Celine Perier ; Miquel Vila ; Matina Maniati ; Ayse Ulusoy ; Deniz Kirik ; David S. Park ; Keiji Wada ; Leonidas Stefanis | Selective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system. |
| 001182 (2012) |
C J Yong-Kee [Canada] ; E. Sidorova ; A. Hanif ; G. Perera ; J E Nash | Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease. |
| 001646 (2011) |
Arman Lira ; Jerzy Kulczycki ; Ruth Slack ; Hymie Anisman ; David S. Park | Involvement of the Fcγ Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss* |
| 001690 (2011) |
C J Yong-Kee [Canada] ; D. Salomonczyk ; J E Nash | Development and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson's disease. |
| 001B26 (2010) |
I. Irrcher ; H. Aleyasin ; E. L. Seifert ; S. J. Hewitt ; S. Chhabra ; M. Phillips ; A. K. Lutz ; M. W. C. Rousseaux ; L. Bevilacqua ; A. Jahani-Asl ; S. Callaghan ; J. G. Maclaurin ; K. F. Winklhofer ; P. Rizzu ; P. Rippstein ; R. H. Kim ; C. X. Chen [Canada] ; E. A. Fon [Canada] ; R. S. Slack ; M. E. Harper ; H. M. Mcbride ; T. W. Mak ; D. S. Park [Corée du Sud, Canada] | Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics |
| 001E00 (2009) |
Mallika Somayajulu-Ni U [Canada] ; Jagdeep K. Sandhu [Canada] ; Jerome Cohen [Canada] ; Marianna Sikorska [Canada] ; Ts Sridhar [Canada, Inde] ; Anca Matei [Canada] ; Henryk Borowy-Borowski [Canada] ; Siyaram Pandey [Canada] | Paraquat induces oxidative stress, neuronal loss in substantia nigra region and Parkinsonism in adult rats: Neuroprotection and amelioration of symptoms by water-soluble formulation of Coenzyme Q10 |
| 002322 (2008) |
Yuhua Jiang [Canada, République populaire de Chine] ; Lin Pei [Canada] ; Shupeng Li [Canada] ; Min Wang [Canada] ; Fang Liu [Canada] | Extracellular dopamine induces the oxidative toxicity of SH‐SY5Y cells |
| 002429 (2007) |
Mojgan Hodaie [Canada] ; Joseph S. Neimat ; Andres M. Lozano | The dopaminergic nigrostriatal system and Parkinson's disease: molecular events in development, disease, and cell death, and new therapeutic strategies. |
| 002466 (2007) |
Matthew P. Mount [Canada] ; Arman Lira ; David Grimes ; Patrice D. Smith ; Sylvie Faucher ; Ruth Slack ; Hymie Anisman ; Shawn Hayley ; David S. Park | Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. |
| 002980 (2005) |
Raymond H. Kim [Canada] ; Patrice D. Smith [Canada] ; Hossein Aleyasin [Canada] ; Shawn Hayley [Canada] ; Matthew P. Mount [Canada] ; Scott Pownall [Canada] ; Andrew Wakeham [Canada] ; Annick J. You-Ten [Canada] ; Suneil K. Kalia [Canada] ; Patrick Horne [Canada] ; David Westaway [Canada] ; Andres M. Lozano [Canada] ; Hymie Anisman [Canada] ; David S. Park [Canada] ; Tak W. Mak [Canada] | Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress |
| 002B94 (2004) |
Patrice D. Smith [Canada] ; Michael J. O'Hare ; David S. Park | CDKs: taking on a role as mediators of dopaminergic loss in Parkinson's disease. |
| 002D82 (2003) |
Zhigao Huang [Canada] ; Raúl De La Fuente-Fernández ; A Jon Stoessl | Etiology of Parkinson's disease. |
| 003598 (2000) |
G. Clarke [Canada] ; R. A. Collins [Canada] ; B. R. Leavitt [Canada] ; D. F. Andrews [Canada] ; M. R. Hayden [Canada] ; C. J. Lumsden [Canada] ; R. R. Mcinnes [Canada] | A one-hit model of cell death in inherited neuronal degenerations |
| 003612 (1999) |
C S Lee [Canada] | Mechanisms of neuronal death in idiopathic parkinsonism. |
| 003A20 (1998) |
C. Schwab [Canada] ; J. C. Steele [États-Unis] ; P. L. Mcgeer [Canada] | Pyramidal neuron loss is matched by ghost tangle increase in Guam parkinsonism-dementia hippocampus |
| 003A21 (1998) |
A. E. Lang [Canada] ; A. M. Lozano [Canada] | Parkinson's disease : Second of two parts |
